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Abstract

Estradiol acts throughout the body; one key target that expresses large numbers of estradiol
receptors is the brain, and specifically the hippocampus. Estradiol can exhibit neuroprotective
effects in the brain. However, the set of pathways through which this occurs is not well
understood. In vitro work has shown that administration of estradiol to hippocampal neurons
inactivates caspase 3, a protease involved in apoptosis and the cleavage of tau. Cleavage of tau
results in the formation of neurofibrillary tangles. Together with formation of amyloid-beta
plaques, this is one of the hallmarks of Alzheimer’s disease. We tested the hypothesis that
administration of estradiol to rats might attenuate the cognitive impairment caused by the
ingestion of a high fat, diabetogenic diet whose long-term consumption causes insulin resistance
and Alzheimer’s disease pathologies. Administration of estradiol unexpectedly did not
ameliorate the impairment seen on a spatial working memory task or a novel object recognition
task. In addition to behavioral measures, post-mortem analyses of hippocampal tissue measured
molecular markers associated with estradiol signaling and memory formation. Ultimately, this
study aims to elucidate mechanisms involved in a possible neuroprotective role for estradiol in
individuals prone to cognitive dysfunction brought about by metabolic disease.
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Introduction
Estradiol is both neurotrophic and neuroprotective, working to preserve cognition during
aging. It is important in maintaining normal brain function, such as consolidation of memory
through membrane interactions and activation of inter-cellular signaling pathways. Estrogen
binds to two receptors, alpha (ERα) and beta (ERβ), which are located throughout the brain,
specifically in the hippocampus and cortex. As these two regions are crucial for acute learning
and memory consolidation, and are most implicated in the development of Alzheimer’s disease,
deficits involving estrogen and its receptors would show an overall decline in cognitive function
(Hwang et al., 2015). It has been shown that treatment with 17β-estradiol improves both spatial
and nonspatial memory in young female mice, but the molecular mechanisms underlying the
effects of estrogen on memory are still unclear (Frick, Pechenino, 2009). Estrogen rapidly affects
cortical memory and synaptic plasticity by binding to the ERβ receptor; it is thought to influence
both information processing and storage in both the cortex and hippocampus by increasing key
synaptic proteins such as GluR1, synaptophysin, and PSD-95 (Logan et al., 2011; Liu et al.,
2008).
In addition to increasing synaptic plasticity, estrogen has also been shown to play a role
in reducing the level of amyloid-beta protein in the brain (Hwang et al., 2015). Aβ toxicity is
one of the indications of Alzheimer’s disease. An in vitro hippocampal neuron cell culture study
conducted by Park et al. (2007) examined the effects of adding preaggregated Aβ to P2 rat
hippocampal neurons in culture. The researchers found that neurons with preaggregated Aβ
exhibited signs of neurodegeneration, which was measured by the amount of neurite retraction
seen in each individual cell. he researchers showed that in cells that were treated with estrogen
twenty-four hours prior to the addition of Aβ preaggregates, only 42 ± 6% of neurons showed
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signs of neurodegeneration. Park et al. also tested to see whether “Aβ-induced programmed cell
death in vitro was accompanied by the activation of caspase 3” (2007). Caspase 3 is one of the
main proteases involved in normal brain development, and is required for typical hallmarks of
apoptosis and changes in cell morphology (Porter and Janicke, 1999). The Park study utilized
hippocampal cell culture neurons with preaggregated Aβ and counterstained these cells with an
active caspase 3 antibody. A TUNEL assay was done which detected DNA fragmentation in
neurons that had received apoptotic signals. The analysis showed that “pretreatment of cultured
hippocampal neurons with estrogen differentially prevented caspase 3 mediated apoptosis in the
presence of preaggregated Aβ” (Park et al., 2007). This was determined by the researchers
comparing the amount of TUNEL(+) and active caspase 3(-) neurons (neurons that had both
active caspase 3 and showed DNA fragmentation) to neurons that received no treatment and
neurons that had active caspase 3 but did not display significant DNA fragmentation. From these
studies Park et al. concluded that estradiol was capable of reducing Aβ-induced apoptosis by
decreasing the number of TUNEL (+) and active caspase 3 (-) hippocampal neurons.
The addition of Aβ to hippocampal neurons in culture might trigger a series of cellular
events that lead to posttranslational changes in the microtubule associated protein tau (Park et al.,
2007). The proteolytic cleavage of tau causes neurofibrillary tangles to accumulate in the brain,
and is executed by caspase 3 (Park et al., 2007). Tau acts as a substrate for caspase 3; as tau is
cleaved, it is itself turned into an effector for apoptosis, generating a self-propagating positive
feedback loop that occurs in an Alzheimer’s disease brain (Fasulo et al., 2005). Gamblin et al.
(2003) showed that active caspase 3 cleaved tau protein at residue 421 and generated a 50-kDa
truncated tau which assembled more rapidly into neurofibrillary tangles than the full-length tau
filaments. This data suggests that a decrease in the factors that prevent this cleavage of tau could
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have some role in the detriments associated with Alzheimer’s disease. Decreasing levels of
estrogen, which commonly occurs with age, could be such a factor.
A growing body of evidence indicates that estrogen administration to neuronal cells can
affect apoptotic processes by partially preventing the activation of caspase 3 and the generation
of cleaved tau proteins in vitro (Park et al., 2007; Kajta et al., 2002). This process is likely to
occur through the activation of caspase inhibitory factor (CIF). A study conducted by Zhang et
al., (2001) indicated that activation of caspase inhibitory factor occurs within ten minutes of
neuron exposure to 17β-estradiol, but not 17α-estradiol in vitro which likely occurs through a
receptor-mediated nongenomic pathway (Zhang et al., 2001). The study showed that
administration of physiological levels of 17β-estradiol to neurons in culture was able to induce a
neuronal CIF that directly inhibited caspase 6 and well as caspases 3, 7, and 8, all of which are
involved in apoptotic processes within the cell (Zhang et al., 2001). These effects were not seen
in astrocyte cell culture. One possible explanation for this could be that astrocytes do not contain
a high level of estrogen receptors compared to other neurons, which likely affects the ability of
estrogen to bind and induce CIF activity in these cells (Zhang et al., 2001). This data gives
probable evidence as to the importance of estrogen involvement in caspase deactivation, and
further provides reasoning for the role of hormones in therapeutic treatments for cognition
deficits.
Due to the vast amount of work showing that estrogen treatment of neurons in vitro is
capable of reducing caspase 3 activation and preventing neuronal cell death, this study explored
whether or not the same effects will be seen in vivo when estradiol is administered to an
Alzheimer’s disease rodent model. Administration of estradiol exhibits neuroprotective effects
in the hippocampus, which allows for insight as to the specific metabolic pathways through
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which this induction occurs. This study explored the hypothesis that inactivation of caspase 3
via estradiol administration allows the rats suffering from metabolic disease to regain normal
cognitive function when put through two different behavioral tests.
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Materials and Methods
Animals
Four groups of male, Sprague-Dawley rats (Charles River, Wilmington, MA) were purchased
and received at 4 weeks of age and doubly housed in enriched conditions on a 12-hour light/dark
schedule (lights on at 7:00am). Room and cage temperatures were maintained at 25 degrees
Celsius. The forty rats were randomly assigned to create four groups of animals in a 2x2 diet x
treatment factorial design. Rats received either standard chow diet (control) and regular water or
a high fat, high fructose diet consisting of 20% fructose, 60% fat (Research Diets #D16030909)
and a 25% fructose water solution. Access was given to food and water ad libitum. Each rat was
handled daily for ten minutes per day prior to receiving microinjection cannula surgery at eleven
weeks of age. After a week of recovery post-surgery, in which the rats were again handled for
ten minutes per day, the forty rats were subjected to glucose tolerance testing, as well as
spontaneous alternation and novel object behavioral testing before being euthanized. All
procedures were approved by the University at Albany, SUNY animal care facility.
Surgical Procedures
Rats were anesthetized with 5% isoflurane and 3% oxygen administered intranasal before
surgery. Throughout the duration of the surgical procedure the isoflurane was lowered to 3%
and oxygen to 2%. All rats received a microinjection guide cannula into the left hippocampus
with coordinates relative to bregma X= +4.6 mm lateral, Y= -5.6 mm posterior to bregma, Z= 3.3 mm ventral from the dura. The nose bar was set at 5.0mm above interaural line (McNay et
al., 2010). Rats received injections of sterile saline (1mL before the procedure and 3 mL postsurgery) in order to maintain hydration. A 1:1 solution of epinephrine/Marcaine was delivered
dropwise after the incision in order to stop any slight bleeding that occurred from the incision.
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Immediately following removal from isoflurane, rats were placed in a warm incubator until they
were recovered from anesthesia and deemed sternal. All rats received a 5mg/kg dose of rimadyl
prior to the incision and a 2 mg rimadyl tablet for three days post-surgery. Rats were given one
week post-surgery for recovery prior to behavioral testing during which they were handled daily
for ten minutes per day.
Glucose Tolerance Testing
One week post-surgery, all rats were subjected to glucose tolerance testing to check fasting blood
glucose levels in order to confirm diabetic status. Rats were fasted for six hours prior to the test,
in which they were only given access to regular water. Blood was obtained by tail prick and
measured using a blood glucose meter (OneTouch Ultra Mini Monitor). After fasting, animals
were given an intra-peritoneal (IP) injection of a 2kg/g dose of 45% glucose solution dissolved in
0.9% saline. Blood glucose was measured at 0 minutes (baseline, prior to injection), 5 minutes,
15 minutes, 30 minutes, 60 minutes, and 120 minutes after injection.
Microinjection Procedures
Microinjections were given to maze-tested animals into the left dorsal hippocampus as
previously described (McNay et al., 2010). The vehicle for the four groups was artificial
extracellular fluid (aECF; McNay & Sherwin, 2004), with experimental groups receiving a
solution of 1.0 µg estradiol (Sigma Aldrich #E4389) in 0.5 µl aECF as described (Packard et al.,
1996). The volume of solution administered to the brain was 0.125 µl per minute for a total
volume of 0.5 µl over the course of four minutes. Injection cannula remained in place for an
additional six minutes after injections in order to ensure proper diffusion of the solution
throughout the brain (McNay et al., 2010). Rats entered the maze ten minutes after the start of
injection.
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Spontaneous Alteration Testing
Spontaneous alternation is a task that is used to examine spatial working memory and acute
learning (McNay et al., 2010). Rats were placed into the center of a four-arm maze, facing arm
“B” each time, and allowed to explore the arms of the maze freely for twenty minutes. The rat
was only counted as visiting a new arm when all four legs of the animal had crossed from the
middle of the maze into the arm being explored. An alternation was counted when a rat visited
all four arms of the maze within any span of five consecutive arm choices; the measurement of
memory testing performance and percent alternation was conducted as described by (McNay et
al., 2010). The maze was cleaned with 70% ethanol at the start of the testing day and in between
each rat being tested. Each rat was returned to their home cage for thirty minutes after
spontaneous alternation testing before being subjected to novel object testing.
Novel Object Recognition Testing
For novel object testing, each rat was placed into a clear plastic box marked with a grid of
sixteen black squares and allowed to freely explore two objects placed in the center of the box
for five minutes. The objects had the same placement and orientation in the box for each animal.
This was used as a baseline measurement to ensure the rat did not prefer one side of the box over
another. After five minutes, rats were removed from the box and subjected to microinjection of
either aECF or estradiol solution as described previously. Rats were returned to their home cages
and 24 hours later tested again with a novel object replacing one of the familiar objects. The
replacement of the familiar object with a novel object was randomized for each animal. Each day
of training and testing was recorded using a video camera, and the amount of time each rat spent
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exploring both objects analyzed using Solomon Coder. The box and every object was cleaned
with 70% ethanol at the beginning of the training day, testing day, and between each animal.
Euthanasia and Tissue Collection
After behavioral testing, rats were anesthetized by intranasal dose of isoflurane and subsequently
decapitated. Brains were removed and correct probe placement confirmed. Only data from
animals with proper probe placement was included in the analysis. The tissues collected
included the left and right hippocampus, frontal cortex, trunk blood, plasma, and both adrenal
glands. The trunk blood collected was spun down at 5000 rpm for 5 minutes, and the serum
fraction collected for analysis.
Tissue Preparation
Collected tissues were immediately placed on dry ice and stored at -80 degrees Celsius for
molecular analysis. The tissue preparation for molecular analysis was prepared as follows: each
side of the dorsal hippocampus was dissected out and immediately processed for western
blotting. Both hippocampal sections were homogenized with 196 µl of homogenization buffer 13
(BioVision) containing protease inhibitor (1:500) (BioVision) from which 30 µl of homogenate
was removed and combined with 200 µl of RIPA buffer containing a protease and phosphatase
inhibitor cocktail (1:200) (ThermoScientific). Frontal cortex sections were homogenized with
210 µl. The initial homogenate was processed according to manufacturer’s instructions
(BioVision) to isolate plasma membrane fractions from the total sample.
Molecular Testing
Western blotting will be used to analyze protein samples from collected tissues. The following
proteins will be analyzed: total tau, phosphorylated tau, cleaved tau, GSK3β, and caspase 3.
Statistical Methods
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All data was analyzed using SPSS software. T-tests were performed, as well as two-way
ANOVA tests to determine significance.
Results
High fat diet, but not estradiol, affects total body weight
Body weight and fat pad weight were measured at euthanasia to confirm effectiveness of the
high fat diet. Figure 1 indicates that rats fed a high fat diet weighed significantly more (Fig. 1A)
and had a greater visceral fat composition compared to body weight (Fig. 1B.) compared to
control animals.
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Figure 1A. Body weight at euthanasia. Rats fed a HFD weighed significantly more at euthanasia
compared to control rats (p<0.05).
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Figure 1B. Epidydimal fat pad weight as a percentage of body weight is an indicator of visceral
fat levels. Rats on the HFD had a significantly greater percentage of fat pad weight compared to
control rats (p<0.05).

High fat diet affects blood glucose levels
Administration of a high fat diet had significant effects on fasting blood glucose levels in all
animals. Animals fed a high fat diet had significantly higher resting blood glucose levels, had
blood glucose levels that spiked higher during the test than control animals, and took
significantly longer to return to baseline blood glucose levels than control animals (Fig. 2A).
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Figure 2A. Results of glucose tolerance test. p<0.05.
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Figure 2B. Bar graph results depicting resting blood glucose levels. HFD animals had
significantly higher resting blood glucose levels compared to control animals. p<0.05.
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Figure 2C. Area under the curve analysis of a glucose tolerance test for control and HFD
animals. HFD animals had significantly higher resting blood glucose, had higher levels of blood
glucose throughout the test, and took longer to return to baseline levels compared to controls.
p<0.05.

Administration of estradiol into the left dorsal hippocampus did not significantly improve spatial
working memory
Through trials of the spontaneous alteration task, the administration of estradiol did not improve
memory functioning or cognition in the rats (Figures 3A & 3B). The groups that were
administered estradiol did not perform any better than the controls did during the spontaneous
alteration task. In addition, the effects of the high fat diet paired with the administration of
estradiol also did not seem to have any effect on memory functioning or cognition.
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Figure 3A. Results of spontaneous alteration task. Neither diet nor estradiol administration had
any significant effect on percent alteration performance. p>0.05.
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Figure 3B. Results of a spontaneous alteration task. Neither diet nor drug administration had any
significant effect on total arm entries in the maze. p>0.05.

Estradiol inhibits cognition seen in rats fed a control diet, and does not improve novel object
recognition
The administration of estradiol to healthy rats had significant effects on recognition of the novel
object. Control rats receiving estradiol did not show a significant preference for the novel object.
This result was surprising, and seems to have some indication that estradiol may have inhibitory
effects in the male rodent brain at the dose given. There were no significant results obtained from
the high fat diet animals given vehicle or estradiol. These animals preferred the novel object over
the familiar object in both treatment groups, which was expected behavior (Figure 4).
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Figure 4. Results for a novel object recognition task. There were no significant differences in
performance in HFD animals based on treatment. There was significant difference in control
animals based on treatment, with control animals receiving estradiol performing worse than
control animals receiving vehicle, indicating that estradiol had some inhibitory effects on
memory. p<0.05 for control animals given estradiol.
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Discussion
The administration of estradiol along with a high fat diet declined to show effects on
memory functioning and cognition that have been seen in previous literature. Previous studies
have shown that estradiol administration increases cognitive performance during spatial working
memory tasks, and that consumption of a high fat diet decreases memory functioning. With this,
we expected to see a decrease in memory functioning in the animals fed the high fat diet, and
expected that animals fed the high fat diet and given estradiol would perform as well as the
controls during the tasks. The data obtained were not significant and gave inconclusive results.
Unexpectedly, animals that were fed the high fat diet did not perform any worse on the
spontaneous alteration task than animals fed standard chow. In addition, the administration of
estradiol to those animals that were on the high fat diet did not ameliorate the memory deficits
that are typically seen in a diet induced obese animal. In the spontaneous alteration task, the
results indicate that the control animals reached between 60-80% alteration. These results are
inconclusive and do not give any insight as to the effects of estradiol administration on spatial
working memory performance. Estradiol administration might work in an inverted-U dose
response curve, meaning that at both low and high doses, the effects of estradiol on memory
functioning are insignificant. It is possible that the dose given to the animals before the task was
not large enough in order to induce the cognitive enhancements we expected to see. In addition,
it is also possible that estradiol might not work in an acute manner, and perhaps only displays
cognitive enhancements in the brain over a longer period of time.
Estradiol did seem to have some effect on spatial memory in control rats during the novel
object recognition task. Animals fed a control diet and given an intrahippocampal injection of
estradiol following the training period of the task performed significantly worse than animals
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given vehicle or on the control diet (p=0.04). This result was unexpected, as previous research
has shown that estradiol has cognitive enhancing effects and should enable animals with
cognitive deficits to perform better, or at least on par with, control animals. Animals fed a
standard diet and receiving a vehicle injection significantly explored the novel object more; this
was expected behavior, as rats are naturally curious animals and will likely explore a novel
object more than one that is familiar. Animals fed a high fat diet and given a vehicle injection did
not significantly explore the novel object more than the familiar object, indicating that these
animals were experiencing cognitive deficits due to consumption of the high fat diet and could
therefore not form memories of which objects had been explored. It was also surprising to see
that animals fed a standard diet and given an injection of estradiol did not significantly explore
the novel object more than the familiar object. We expected animals in both the control/estradiol
and HFD/estradiol groups to explore the novel object significantly more than all other groups, as
these rats would have experienced the neuroprotective effects of estradiol if estradiol works as a
cognitive enhancer. The results of the control/estradiol group seem to indicate that estradiol may
be acting as a cognitive inhibitor at the dose given, and would not improve memory in a diet
induced diabetic rat. These abnormal results could be explained due to the dose of estradiol given
for both behavioral tasks. It is possible that the dose of estradiol given to the rats was not high
enough to warrant a substantial effect on cognition, particularly in male rats. In order to gain
more significant results and fully understand the role of estradiol in memory formation, differing
doses of estradiol will have to be given to determine the best dose for cognitive enhancement.
A lack of behavioral effects does not mean that estradiol has no molecular effects in the
brain. In order to determine whether or not estradiol affects protein expression in the male rat
brain during memory formation, western blot analysis will be conducted on various brain
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samples collected. Caspase 3, GSK3β, and different variations of tau protein will be analyzed for
their expression levels in order to elucidate the specific pathway through which estradiol acts in
the brain. It is expected that animals fed a high fat diet will exhibit higher levels of
neurofibrillary tau tangles, and that those given estradiol treatments will have lower levels of
cleaved tau and inactivated caspase 3 proteins. Determining the levels of protein expression in
the hippocampus of these animals will give further insight as to how exactly estradiol works in
the hippocampus to enhance spatial memory and cognition.
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